Literature DB >> 7621595

CDR3 regions in the preimmune VH B cell repertoire of lpr mice.

M E Alarcón-Riquelme1, C Fernández.   

Abstract

Previous studies have suggested that the CDR3 genetic element of the heavy chain variable region of autoantibodies is important in determining reactivity against self antigens, particularly against DNA. The lpr mutation was recently found to encode for a defective form of the fas protein, a molecule important for the transmission of the apoptotic signal into cells. Our aim was to determine whether CDR3 elements similar to those described for autoantibody-producing hybridomas derived from lupus-prone strains could be found in the preimmune repertoire of B cells in mice with the lpr mutation. The analysis of the junctions of the VH-C mu functional rearrangements derived by polymerase chain reaction (PCR) amplification of RNA obtained from splenic small, resting cells stimulated with lipopolysaccharide (LPS) from male lpr mice showed that a large proportion of them expressed D genes in the unusual reading frames 2 and 3. Two of the lpr joints were formed by D-D fusions. Similarly, nearly half of the lpr sequences had arginines, an amino acid which promotes binding to dsDNA and is seldom observed in normal junctions. Our results show that the preimmune repertoire of lpr animals has abnormal CDR3 elements which may result from a failure at different levels of selection. The antigen-dependent selection of such elements that leads to the expansion of specific, high-affinity anti-dsDNA antibody-producing clones might depend on other genetic factors not found in the C57B1/6-lpr strains but in the MRL-lpr.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7621595      PMCID: PMC1553283          DOI: 10.1111/j.1365-2249.1995.tb02279.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  14 in total

1.  Structure and function of anti-DNA autoantibodies derived from a single autoimmune mouse.

Authors:  M J Shlomchik; A H Aucoin; D S Pisetsky; M G Weigert
Journal:  Proc Natl Acad Sci U S A       Date:  1987-12       Impact factor: 11.205

2.  Induction of various autoantibodies by mutant gene lpr in several strains of mice.

Authors:  S Izui; V E Kelley; K Masuda; H Yoshida; J B Roths; E D Murphy
Journal:  J Immunol       Date:  1984-07       Impact factor: 5.422

3.  Improved oligonucleotide site-directed mutagenesis using M13 vectors.

Authors:  P Carter; H Bedouelle; G Winter
Journal:  Nucleic Acids Res       Date:  1985-06-25       Impact factor: 16.971

4.  Lymphoproliferation disorder in mice explained by defects in Fas antigen that mediates apoptosis.

Authors:  R Watanabe-Fukunaga; C I Brannan; N G Copeland; N A Jenkins; S Nagata
Journal:  Nature       Date:  1992-03-26       Impact factor: 49.962

5.  Expression of the B cell repertoire in lpr mice; abnormal expansion of a few VHJ558 germ-line genes.

Authors:  M E Alarcón-Riquelme; C Fernández
Journal:  Clin Exp Immunol       Date:  1995-02       Impact factor: 4.330

Review 6.  Lpr and gld: single gene models of systemic autoimmunity and lymphoproliferative disease.

Authors:  P L Cohen; R A Eisenberg
Journal:  Annu Rev Immunol       Date:  1991       Impact factor: 28.527

7.  VH-gene expression in murine lipopolysaccharide blasts distributes over the nine known VH-gene groups and may be random.

Authors:  R Dildrop; U Krawinkel; E Winter; K Rajewsky
Journal:  Eur J Immunol       Date:  1985-11       Impact factor: 5.532

8.  Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease.

Authors:  J M Chirgwin; A E Przybyla; R J MacDonald; W J Rutter
Journal:  Biochemistry       Date:  1979-11-27       Impact factor: 3.162

9.  Anti-DNA antibodies from autoimmune mice arise by clonal expansion and somatic mutation.

Authors:  M Shlomchik; M Mascelli; H Shan; M Z Radic; D Pisetsky; A Marshak-Rothstein; M Weigert
Journal:  J Exp Med       Date:  1990-01-01       Impact factor: 14.307

10.  Most peripheral B cells in mice are ligand selected.

Authors:  H Gu; D Tarlinton; W Müller; K Rajewsky; I Förster
Journal:  J Exp Med       Date:  1991-06-01       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.